Literature DB >> 4008200

Defects in cortisol-metabolizing enzymes in primary open-angle glaucoma.

B I Weinstein, P Munnangi, G G Gordon, A L Southren.   

Abstract

Assays of cortisol-metabolizing enzymes in homogenates of human trabecular meshwork cells under optimal conditions revealed two defects in primary open-angle glaucoma (POAG): one is a marked increase in delta 4-reductase and the other is a decrease in 3-oxidoreductase. Experiments indicated that the differences in enzyme activities seen between POAG and nonPOAG trabecular meshwork derived cell homogenates were due to altered amounts of enzymes rather than to alterations in cofactor availability, pH, or endogenous activators or inhibitors. This clearly demonstrates an enzymatic defect(s) in POAG which may be the basis for the ocular hypertension and sensitivity to exogenous glucocorticoids seen in this disorder.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008200

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Spliceosome protein (SRp) regulation of glucocorticoid receptor isoforms and glucocorticoid response in human trabecular meshwork cells.

Authors:  Ankur Jain; Robert J Wordinger; Thomas Yorio; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

2.  Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix.

Authors:  Vijay Krishna Raghunathan; Joshua T Morgan; Shin Ae Park; Darren Weber; Brett S Phinney; Christopher J Murphy; Paul Russell
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

Review 3.  Glucocorticoid therapy and ocular hypertension.

Authors:  Adnan Dibas; Thomas Yorio
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

4.  Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits.

Authors:  Zhengyu Song; Yuanyuan Gong; Haiyun Liu; Qiushi Ren; Xiaodong Sun
Journal:  Mol Vis       Date:  2011-08-04       Impact factor: 2.367

5.  Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres.

Authors:  M J Rodrigo; D Garcia-Herranz; A Aragón-Navas; M Subias; T Martinez-Rincón; S Mendez-Martínez; M J Cardiel; J García-Feijoo; J Ruberte; R Herrero-Vanrell; L Pablo; E Garcia-Martin; I Bravo-Osuna
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

6.  Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.

Authors:  Gaurang C Patel; J Cameron Millar; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

7.  Dexamethasone and Glucocorticoid-Induced Matrix Temporally Modulate Key Integrins, Caveolins, Contractility, and Stiffness in Human Trabecular Meshwork Cells.

Authors:  Felix Yemanyi; Hasna Baidouri; Alan R Burns; VijayKrishna Raghunathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.